CSIMarket


Pdl Biopharma, Inc.  (PDLI)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Pdl Biopharma, Inc.

PDLI's Fundamental analysis






Pdl Biopharma's sales fell by -5.17 % in III. Quarter 2019 from the same quarter a year ago. Ranking at No. 1168

Biotechnology & Drugs industry recorded growth of revenues by 5.65 %

Pdl Biopharma net loss deacreased by in III. Quarter 2019 year on year, Pdl Biopharma net loss increased by -84 % in III. Quarter 2019 year on year,

More on PDLI's Growth


Pdl Biopharma
current PE on trailing twelve month basis is above Biotechnology & Drugs industry average.

Pdl Biopharma PEG ratio is at -0.27 , above Biotechnology & Drugs industry PEG average of 0.Biotechnology & Drugs industry recorded net loss in trailing twelve months.
Company
32.72
PE TTM   
Industry
0
PE TTM    
Company's Price to Sales ratio is at 2.62.
Biotechnology & Drugs industry's Price to Sales ratio is at 4.55.

Pdl Biopharma Price to Book Ratio is at 0.55 lower than Indusry Avg. of 667.23. and higher than S&P 500 Avg. of -0.02

More on PDLI's Valuation
 
 Total Debt (Millions $) 132
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 7.98
 Tangible Book Value (Per Share $) 5.22

Pdl Biopharma
current PE on trailing twelve month basis is above Biotechnology & Drugs industry average.

Pdl Biopharma PEG ratio is at -0.27 , above Biotechnology & Drugs industry PEG average of 0.Biotechnology & Drugs industry recorded net loss in trailing twelve months.
Company
32.72
PE TTM   
Industry
0
PE TTM    
Company's Price to Sales ratio is at 2.62.
Biotechnology & Drugs industry's Price to Sales ratio is at 4.55.

Pdl Biopharma Price to Book Ratio is at 0.55 lower than Indusry Avg. of 667.23. and higher than S&P 500 Avg. of -0.02

More on PDLI's Valuation

 Market Capitalization (Millions $) 353
 Shares Outstanding (Millions) 113
 Employees -
 Revenues (TTM) (Millions $) 135
 Net Income (TTM) (Millions $) 19
 Cash Flow (TTM) (Millions $) 31
 Capital Exp. (TTM) (Millions $) 19
 Total Debt (Millions $) 132
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover Ratio (TTM) 7.98
 Tangible Book Value (Per Share $) 5.22

 Market Capitalization (Millions $) 353
 Shares Outstanding (Millions) 113
 Employees -
 Revenues (TTM) (Millions $) 135
 Net Income (TTM) (Millions $) 19
 Cash Flow (TTM) (Millions $) 31
 Capital Exp. (TTM) (Millions $) 19

PDLI's Profitability Comparisons
Pdl Biopharma achieved increase in profitability, primarily through cost control. Operating Margin grew in III. Quarter 2019 to 21.38 %.







  Ratio
   Capital Ratio (MRQ) 9.94
  Total Debt to Equity (MRQ) 0.21
  Tangible Leverage Ratio (MRQ) 0.39
  Asset Turnover Ratio (TTM) 0.15
  Inventory Turnover Ratio (TTM) 2.96



Pdl Biopharma achieved increase in profitability, primarily through cost control. Operating Margin grew in III. Quarter 2019 to 21.38 %.



More on PDLI's Key Ratios





             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ENRJ's Profile

Stock Price

ENRJ's Financials

Business Description

Fundamentals

Charts & Quotes

ENRJ's News

Suppliers

ENRJ's Competitors

Customers & Markets

Economic Indicators

ENRJ's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071